NUWELLIS INC (NUWE) Stock Price & Overview
NASDAQ:NUWE • US67113Y7022
Current stock price
The current stock price of NUWE is 1.09 USD. Today NUWE is down by 0%. In the past month the price decreased by -26.35%. In the past year, price decreased by -96.87%.
NUWE Key Statistics
- Market Cap
- 2.518M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1,630.02
- Dividend Yield
- N/A
NUWE Stock Performance
NUWE Stock Chart
NUWE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NUWE. When comparing the yearly performance of all stocks, NUWE is a bad performer in the overall market: 97.76% of all stocks are doing better.
NUWE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NUWE. The financial health of NUWE is average, but there are quite some concerns on its profitability.
NUWE Earnings
On March 11, 2026 NUWE reported an EPS of -1.5 and a revenue of 2.42M. The company beat EPS expectations (5.73% surprise) and beat revenue expectations (2.89% surprise).
NUWE Forecast & Estimates
For the next year, analysts expect an EPS growth of 98.39% and a revenue growth -8.15% for NUWE
NUWE Groups
Sector & Classification
NUWE Financial Highlights
Over the last trailing twelve months NUWE reported a non-GAAP Earnings per Share(EPS) of -1630.02. The EPS increased by 91.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -207.46% | ||
| ROE | -423.19% | ||
| Debt/Equity | 0 |
NUWE Ownership
NUWE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NUWE
Company Profile
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Company Info
IPO: 2012-02-16
NUWELLIS INC
12988 Valley View Rd
Eden Prairie MINNESOTA 55344 US
CEO: Nestor Jaramillo
Employees: 38
Phone: 18009279800
NUWELLIS INC / NUWE FAQ
Can you describe the business of NUWELLIS INC?
Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Can you provide the latest stock price for NUWELLIS INC?
The current stock price of NUWE is 1.09 USD.
What is the dividend status of NUWELLIS INC?
NUWE does not pay a dividend.
How is the ChartMill rating for NUWELLIS INC?
NUWE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is NUWELLIS INC (NUWE) stock traded?
NUWE stock is listed on the Nasdaq exchange.
Should I buy NUWE stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NUWE.
What is the ownership structure of NUWELLIS INC (NUWE)?
You can find the ownership structure of NUWELLIS INC (NUWE) on the Ownership tab.